New cases tested for RR-/MDR-TB in Americas (WHO region)

Americas (WHO region): New cases tested for RR-/MDR-TB was 70.0% in 2024. ◆ Volatile

Latest (2024)
70.0%
Change on year
up 4.5%
Rank
9th
of 11 groups
All-time high
70.0%
in 2024
All-time low
8.4%
in 2010
Years of data
20
2005–2024

New cases tested for RR-/MDR-TB in Americas (WHO region), 2005–2024

0204060802005201420242005: 112006: 102007: 102008: 9.62009: 8.52010: 8.42011: 112012: 222013: 242014: 242015: 442016: 522017: 482018: 402019: 432020: 522021: 592022: 602023: 672024: 70

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for new cases tested for rr-/mdr-tb in Americas (WHO region) is 70.0%, measured in 2024. That is the highest value across all 20 years on record.

Compared with earlier readings it is up 4.5% on the previous year and up 191.7% over ten years.

Over the whole period, new cases tested for rr-/mdr-tb in Americas (WHO region) peaked at 70.0% in 2024 and was at its lowest, 8.4%, in 2010.

The series is highly variable year to year, so single readings are best treated with caution.

New cases tested for RR-/MDR-TB in Americas (WHO region), year by year

Annual values for New cases tested for RR-/MDR-TB (%) in Americas (WHO region), 2005 to 2024.
Year Value Change
2005 11.0%
2006 10.0% -9.1%
2007 10.0% +0.0%
2008 9.6% -4.0%
2009 8.5% -11.5%
2010 8.4% -1.2%
2011 11.0% +31.0%
2012 22.0% +100.0%
2013 24.0% +9.1%
2014 24.0% +0.0%
2015 44.0% +83.3%
2016 52.0% +18.2%
2017 48.0% -7.7%
2018 40.0% -16.7%
2019 43.0% +7.5%
2020 52.0% +20.9%
2021 59.0% +13.5%
2022 60.0% +1.7%
2023 67.0% +11.7%
2024 70.0% +4.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 9.8% 8.5% 11.0% 5
2010s 31.6% 8.4% 52.0% 10
2020s 61.6% 52.0% 70.0% 5

More health data for Americas (WHO region)

All data for Americas (WHO region) →

Frequently asked questions

What is new cases tested for rr-/mdr-tb in Americas (WHO region)?
New cases tested for rr-/mdr-tb in Americas (WHO region) was 70.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest new cases tested for rr-/mdr-tb recorded in Americas (WHO region)?
The highest recorded value was 70.0% in 2024.
What is the lowest new cases tested for rr-/mdr-tb recorded in Americas (WHO region)?
The lowest recorded value was 8.4% in 2010.
How does Americas (WHO region) rank for new cases tested for rr-/mdr-tb?
Americas (WHO region) ranks 9th out of 11 groups with data for 2024.
Is new cases tested for rr-/mdr-tb rising or falling in Americas (WHO region)?
Over the last ten years it is up 191.7%. The long-run trend across the full record is volatile.
Where does this Americas (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

New cases tested for RR-/MDR-TB in Americas (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 September 2026, from https://health.statizoid.com/stat/new-cases-tested-for-rr-mdr-tb-percent/americas-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/new-cases-tested-for-rr-mdr-tb-percent/americas-who-region/">New cases tested for RR-/MDR-TB in Americas (WHO region)</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed